3-Methylxanthine

3-Methylxanthine

SCHEMBL4020124

Cn1c(=O)[nH]c(=O)c2[nH]cnc21.[NaH].[NaH]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 9/20 0.62
PDE4A P27815 8/20 0.62
PDE4B Q07343 8/20 0.62
PDE4C Q08493 8/20 0.62
PDE4D Q08499 8/20 0.62
ADORA2B P29275 6/20 0.62
ADORA3 P0DMS8 3/20 0.62
ADORA1 P30542 2/20 0.62
HPGD P15428 1/20 0.62
BLM P54132 1/20 0.62
PDE3A Q14432 1/20 0.62
HSD17B10 Q99714 1/20 0.62
ATAD2 Q6PL18 1/20 0.54
PIK3CD O00329 1/20 0.53
ALPL P05186 1/20 0.53
TMIGD3 P0DMS9 1/20 0.53
CYP2C19 P33261 1/20 0.53
HIF1A Q16665 1/20 0.53
PNP P00491 1/20 0.51
CYP3A4 P08684 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
3-Methylxanthine SCHEMBL237146 0.98 ADORA2A (0.64) ADORA2APDE4APDE4BPDE4CPDE4D
3-Methylxanthine SCHEMBL30753411 0.96 ADORA2A (0.62) ADORA2APDE4APDE4BPDE4CPDE4D
3-Methylxanthine SCHEMBL9317914 0.96 ADORA2A (0.62) ADORA2APDE4APDE4BPDE4CPDE4D
3-Methylxanthine SCHEMBL2791774 0.88 ADORA2A (0.58) ADORA2APDE4APDE4BPDE4CPDE4D
3-Methylxanthine SCHEMBL1892894 0.86 ADORA2B (0.77) ADORA2APDE4APDE4BPDE4CPDE4D
3-Methylxanthine SCHEMBL4018085 0.86 ADORA2A (0.52) ADORA2APDE4APDE4BPDE4CPDE4D
Theobromine SCHEMBL4024314 0.85 MAPK1 (0.75) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL17164064 0.84 ATAD2 (0.51) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL864455 0.80 ADORA2A (0.58) ADORA2APDE4APDE4BPDE4CPDE4D
Caffeine SCHEMBL17748263 0.80 ADORA2A (0.61) ADORA2APDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101896484-B Theobromine production process PERRIGO TRADING SHANGHAI CO LT 2013-06-12 CN claimed
CN-101896484-A Theobromine production process PERRIGO TRADING SHANGHAI CO LT 2010-11-24 CN claimed
CN-101220032-B Novel method for producing theobromine with 3_methylxanthine disodium salt methylating BAILIGAO TRADE SHANGHAI CO LTD 2010-06-02 CN claimed
WO-2009089677-A1 THEOBROMINE PRODUCTION PROCESS PERRIGO TRADING (SHANGHAI) CO., LTD. (CN) 2009-07-23 WO claimed
CN-101220032-A Novel method for producing theobromine with 3_methylxanthine disodium salt methylating SHANDONG XINHUA PHARMACEUTICAL (CN) 2008-07-16 CN claimed
CN-117466894-A Preparation method of pentoxifylline 河北一品生物医药有限公司 2024-01-30 CN disclosed
CN-101896484-B Theobromine production process PERRIGO TRADING SHANGHAI CO LT 2013-06-12 CN disclosed
CN-101896484-B Theobromine production process PERRIGO TRADING SHANGHAI CO LT 2013-06-12 CN disclosed
CN-101896484-A Theobromine production process PERRIGO TRADING SHANGHAI CO LT 2010-11-24 CN disclosed
CN-101896484-A Theobromine production process PERRIGO TRADING SHANGHAI CO LT 2010-11-24 CN disclosed
CN-101220032-B Novel method for producing theobromine with 3_methylxanthine disodium salt methylating BAILIGAO TRADE SHANGHAI CO LTD 2010-06-02 CN disclosed
CN-101220032-B Novel method for producing theobromine with 3_methylxanthine disodium salt methylating BAILIGAO TRADE SHANGHAI CO LTD 2010-06-02 CN disclosed
WO-2009089677-A1 THEOBROMINE PRODUCTION PROCESS PERRIGO TRADING (SHANGHAI) CO., LTD. (CN) 2009-07-23 WO disclosed
WO-2009089677-A1 THEOBROMINE PRODUCTION PROCESS PERRIGO TRADING (SHANGHAI) CO., LTD. (CN) 2009-07-23 WO disclosed
CN-101220032-A Novel method for producing theobromine with 3_methylxanthine disodium salt methylating SHANDONG XINHUA PHARMACEUTICAL (CN) 2008-07-16 CN disclosed
CN-101220032-A Novel method for producing theobromine with 3_methylxanthine disodium salt methylating SHANDONG XINHUA PHARMACEUTICAL (CN) 2008-07-16 CN disclosed
US-5728686-A TREATMENT OF MUSCULAR DYSTROPHY HOECHST AKTIENGESELLSCHAFT (DE) 1998-03-17 US disclosed
CN-1158855-A Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmacueticals HOECHST AG (DE) 1997-09-10 CN disclosed